Table 2 EGFR, membrane EGFR and pEGFR expression in cervical carcinoma patients
Antigen | Immunoreactivity | Overall, N (%) | Squamous cell carcinoma, N (%) | Adeno(squamous) carcinoma, N (%) | P-valuea |
|---|---|---|---|---|---|
EGFR | Negative | 18 (11) | 4 (4) | 14 (24) | 0.002 |
Weak | 19 (12) | 11 (11) | 8 (13) | ||
Moderate | 62 (40) | 41 (42) | 21 (36) | ||
Strong | 58 (37) | 42 (43) | 16 (27) | ||
mEGFR | Negative | 24 (15) | 6 (6) | 17 (29) | <0.001 |
Weak | 22 (14) | 12 (12) | 10 (16) | ||
Moderate | 61 (38) | 42 (43) | 19 (31) | ||
Strong | 52 (33) | 37 (38) | 15 (24) | ||
pEGFR | Negative | 94 (60) | 55 (59) | 39 (63) | 0.841 |
Positive | 62 (40) | 39 (41) | 23 (37) |
